Metallopeptide compositions for treatment of sexual dysfunction

Details Metallopeptide compositions for treatment of sexual dysfunction Metallopeptide compositions for treatment of sexual dysfunction

2008-07-08

2008-07-08

Lukton, David (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S016700, C514S017400, C514S492000, C530S329000, C530S330000, C530S331000

Reexamination Certificate

active

07396814

ABSTRACT:
Metallopeptide compositions are provided for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction. The metallopeptides include at least one, and preferably two, aromatic amino acid side chain moieties, and are further characterized in that the metallopeptides preferably do not bind or significantly bind to a melanocortin receptor.

REFERENCES:
patent: 5408036 (1995-04-01), Ghadiri

Affiliated with

Also associated with

Rating

Metallopeptide compositions for treatment of sexual dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metallopeptide compositions for treatment of sexual dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metallopeptide compositions for treatment of sexual dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2783525